Breaking News

Aldevron to Build 14-Acre Gene Therapy Mfg. Campus

Annual capacity will exceed $1 billion of plasmid DNA, RNA, gene editing enzymes, and other biologics

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Aldevron, a producer of plasmid DNA, proteins, mRNA and antibodies, is planning an expansion at its 14-acre campus headquarters in Fargo, ND, which will begin in August. Upon completion, the annual capacity will exceed $1 billion of plasmid DNA, RNA, gene editing enzymes, and other biologics.  The first building will increase Aldevron’s GMP and GMP-Source production capacity up to 10 times its current output. The new 189,000 sq.-ft. building will connect to the existing GMP facility and is ex...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters